Amicus Therapeutics Statistics

Total Valuation

LON:0HF9 has a market cap or net worth of GBP 1.54 billion. The enterprise value is 1.69 billion.

Market Cap	1.54B
Enterprise Value	1.69B

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+3.12%
Shares Change (QoQ)	+0.48%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	258.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.68
PB Ratio	10.31
P/TBV Ratio	n/a
P/FCF Ratio	1,241.32
P/OCF Ratio	560.37
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 34.97, with an EV/FCF ratio of 1,357.90.

EV / Earnings	-74.34
EV / Sales	4.14
EV / EBITDA	34.97
EV / EBIT	47.02
EV / FCF	1,357.90

Financial Position

The company has a current ratio of 3.34, with a Debt / Equity ratio of 2.29.

Current Ratio	3.34
Quick Ratio	2.22
Debt / Equity	2.29
Debt / EBITDA	6.90
Debt / FCF	275.79
Interest Coverage	0.98

Financial Efficiency

Return on equity (ROE) is -18.12% and return on invested capital (ROIC) is 4.93%.

Return on Equity (ROE)	-18.12%
Return on Assets (ROA)	3.95%
Return on Invested Capital (ROIC)	4.93%
Return on Capital Employed (ROCE)	7.50%
Revenue Per Employee	842,456
Profits Per Employee	-45,560
Employee Count	499
Asset Turnover	0.72
Inventory Turnover	0.53

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.58% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-34.58%
50-Day Moving Average	8.14
200-Day Moving Average	9.86
Relative Strength Index (RSI)	33.97
Average Volume (20 Days)	901

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.47

Income Statement

In the last 12 months, LON:0HF9 had revenue of GBP 420.39 million and -22.73 million in losses. Loss per share was -0.07.

Revenue	420.39M
Gross Profit	380.85M
Operating Income	36.99M
Pretax Income	-2.49M
Net Income	-22.73M
EBITDA	43.36M
EBIT	36.99M
Loss Per Share	-0.07

Full Income Statement

Balance Sheet

The company has 193.94 million in cash and 343.24 million in debt, giving a net cash position of -149.30 million.

Cash & Cash Equivalents	193.94M
Total Debt	343.24M
Net Cash	-149.30M
Net Cash Per Share	n/a
Equity (Book Value)	149.81M
Book Value Per Share	0.49
Working Capital	277.02M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.76 million and capital expenditures -1.51 million, giving a free cash flow of 1.24 million.

Operating Cash Flow	2.76M
Capital Expenditures	-1.51M
Free Cash Flow	1.24M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 90.60%, with operating and profit margins of 8.80% and -5.41%.

Gross Margin	90.60%
Operating Margin	8.80%
Pretax Margin	-0.59%
Profit Margin	-5.41%
EBITDA Margin	10.31%
EBIT Margin	8.80%
FCF Margin	0.30%

Dividends & Yields

LON:0HF9 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.12%
Shareholder Yield	-3.12%
Earnings Yield	-1.47%
FCF Yield	0.08%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HF9 has an Altman Z-Score of -0.4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.4
Piotroski F-Score	n/a